Four medications used to treat rheumatoid arthritis will soon get stronger warning labels. The Food and Drug Administration has ordered new warnings be added to Remicade, Enbrel, Cimzia, and Humira (drugs prescribed to treat rheumatoid arthritis, Crohn's disease, and other conditions).
The FDA says those drugs can expose some patients to potentially fatal fungal infections. The FDA says it has received 240 reports of infections, including 12 that lead to fatal complications.
If you are concerned, talk to your doctor.